Collateral for a security interest recorded Jan 18, 2023 (Oxford Finance LLC).
Term ends Mar 21, 2039 · Low confidence
20-year base term ends Mar 21, 2039
Held by Nevakar Injectables Inc.
Filed Nov 15, 2021 as application 17/526,786 · Granted Nov 5, 2024
Base term plus 186 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2019
2039
Clock starts
Mar 21, 2019
Mar 21, 2019
Term ends
Mar 21, 2039
Mar 21, 2039
Granted
Nov 5, 2024
Nov 5, 2024
base term
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
186
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,653,646, US 11,071,719, US 11,083,698, US 11,207,280.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 186 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 21, 2019, when application 16/360,995, the earliest non-provisional in its chain, was filed (this one was filed Nov 15, 2021); a parent in its chain could not be resolved (the next row) | Mar 21, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +186 days, USPTO patent term adjustment record | Sep 23, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,653,646, US 11,071,719, US 11,083,698, US 11,207,280) | capped to Mar 21, 2039 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16821785, 16788831, 16360995 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Mar 21, 2039 | Low confidence |
This family
| US 10,653,646 | In force Mar 2039 | Mar 2039 |
| US 11,071,719 | In force Mar 2039 | Mar 2039 |
| US 11,207,280 | In force Mar 2039 | Mar 2039 |
| US 11,083,698 | In force Mar 2039 | Mar 2039 |
| US 12,133,837 | this patent Mar 2039 | Mar 2039 |
| US 12,508,238 | In force Mar 2039 | Mar 2039 |
| US 12,533,328 | In force Mar 2039 | Mar 2039 |
| Application 19/202,994 | Pending not computed | not computed |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 24, 2022 Reel 58748, frame 760 | Puri, Reema Ajitkumar; Akasapu, Prem Sagar; Soppimath, Kumaresh; Ilitchev, Iouri V.; Patel, Milan; Tendulkar, Pooja H. | Nevakar, LLC | Assignment of Assignor's Interest |
| Jan 24, 2022 Reel 58748, frame 819 | Nevakar Inc. | Nevakar Injectables Inc. | Assignment of Assignor's Interest |
| Jan 24, 2022 Reel 58829, frame 994 | Nevakar, LLC | Nevakar Inc. | Change of Name |
| Jan 18, 2023 Reel 62405, frame 329 | Nevakar Injectables Inc. | Oxford Finance LLC | Security Interest |
| May 4, 2023 Reel 63545, frame 646 | Nevakar Injectables Inc. | H.I.G. Bio - Nevakar, L.P. | Patent Security Agreement |
| May 9, 2023 Reel 63583, frame 948 | Nevakar Injectables Inc. | Novaquest Co.-Investment Fund IX, L.P. | Security Interest |
| May 9, 2023 Reel 63588, frame 122 | Oxford Finance LLC | Novaquest Co.-Investment Fund X, L.P. | Security Interest |
| Sep 3, 2026 Reel 75902, frame 289 | Novaquest Co.-Investment Fund IX, L.P. | Nevakar Injectables Inc. | Release of Security Interest |
| Sep 3, 2026 Reel 75902, frame 359 | H.I.G. Bio - Nevakar, L.P. | Nevakar Injectables Inc. | Release of Security Interest |
| Sep 3, 2026 Reel 76340, frame 73 | Novaquest Co.-Investment Fund X, L.P. | Nevakar Inc.; Nevakar Injectables Inc.; Vyluma Inc. | Release of Security Interest |
| Sep 3, 2026 reel/frame not recorded | Novaquest Co.-Investment Fund X, L.P. | Nevakar Inc. | Release of Security Interest |
| Sep 3, 2026 reel/frame not recorded | Novaquest Co.-Investment Fund X, L.P. | Nevakar Injectables Inc. | Release of Security Interest |
| Sep 3, 2026 reel/frame not recorded | Novaquest Co.-Investment Fund X, L.P. | Vyluma Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2039
Term ends Mar 21, 2039. Maintenance fees still fall due before then
Note
The 186 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,653,646, US 11,071,719, US 11,083,698, US 11,207,280.
Citations
3
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.